Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu

CBD-Proline Cocrystal Pharmaceutical Formulation

Z-ARCHIVE-Cannabis Patent Forecast®

April 9, 2020

A patent (US Pat. 10,604,467) for a medical CBD L-Proline cocrystal published this week assigned to Artelo Biosciences. A cocrystal can have more desirable properties as a pharmaceutical such as increased bioavailability giving value to this IP asset.

Artelo Biosciences uses biopharmaceutical techniques to develop novel therapeutics designed to act on the endocannabinoid system. Discover other novel publications conveniently categorized and displayed on Magic Number’s Patent Radian™.

Selective Focus Photography Crystals Stones

Relevant Patent Documents

Patent US10604467  


View Patent Forecast®

Cannabis is now legally being used to treat a wide variety of medical conditions, including chronic pain, alcoholism, anxiety, nausea (from chemotherapy) and epilepsy.

Z-ARCHIVE-Cannabis   Patent Forecast®

View Patent Forecast® Top Corporations News and Insights Data Visualization

Cannabis is now legally being used to treat a wide variety of medical conditions, including chronic pain, alcoholism, anxiety, nausea (from chemotherapy) and epilepsy.



301